GlassScriptPhysician profile
Ravinder K Wali
NPI 1821030933
$312.45
in general payments reported to CMS, 2019-2025
5 companies · none reported in 2025
See the full distribution for Nephrology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.30 · 2020: $82.46 · 2021: $110 · 2023: $44.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $44.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $44.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Veloxis Pharmaceuticals, INC. | $107.82 | 2019-2023 | |
| Mallinckrodt Hospital Products INC. | $67.15 | 2021 | |
| Vifor Pharma, INC. | $67.02 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $52.85 | 2020 | |
| Astellas Pharma US INC | $17.61 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ravinder Wali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.